Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)

Conditions

• Fungal Infection

Interventions

• DRUG: Posaconazole
• DRUG: Dextrose 5% in water

Sponsor

Merck Sharp & Dohme LLC